TPEN selectively eliminates lymphoblastic B cells from bone marrow pediatric acute lymphoblastic leukemia patients
Tóm tắt
B-cell acute lymphoblastic leukemia (B-ALL) is a hematologic disorder characterized by the abnormal proliferation and accumulation of immature B-lymphoblasts arrested at various stages of differentiation. Despite advances in treatment, a significant percentage of pediatric patients with precursor B-ALL still relapse. Therefore, alternative therapies are needed to improve the cure rates for pediatric patients. TPEN (N, N, N’, N’-tetrakis(2-pyridylmethyl)-ethylenediamine) is a pro-oxidant agent capable of selectively inducing apoptosis in leukemia cell lines. Consequently, it has been suggested that TPEN could be a potential agent for oxidative therapy. However, it is not yet known whether TPEN can selectively destroy leukemia cells in a more disease-like model, for example, the bloodstream and bone marrow (BM), ex vivo. This investigation is an extension of a previous study that dealt with the effect of TPEN on ex vivo isolated/purified refractory B-ALL cells. Here, we evaluated the effect of TPEN on whole BM from nonleukemic patients (control) or pediatric patients diagnosed with de novo B-ALL or refractory B-ALL cells by analyzing the hematopoietic cell lineage marker CD34/CD19. Although TPEN was innocuous to nonleukemic BM (n = 3), we found that TPEN significantly induced apoptosis in de novo (n = 5) and refractory B-ALL (n = 6) leukemic cell populations. Moreover, TPEN significantly increased the counts of cells positive for the oxidation of the stress sensor protein DJ-1, a sign of the formation of H2O2, and significantly increased the counts of cells positive for the pro-apoptotic proteins TP53, PUMA, and CASPASE-3 (CASP-3), indicative of apoptosis, in B-ALL cells. We demonstrate that TPEN selectively eliminates B-ALL cells (CD34 + /CD19 +) but no other cell populations in BM (CD34 + /CD19-; CD34-/CD19 + ; CD34-/CD19-) independent of age, diagnosis status (de novo or refractory), sex, karyotype, or immunophenotype. Understanding TPEN-induced cell death in leukemia cells provides insight into more effective therapeutic oxidation-inducing anticancer agents.
Tài liệu tham khảo
Cassier PA, Castets M, Belhabri A, Vey N (2017) Targeting apoptosis in acute myeloid leukemia. Br J Cancer 117:1089–1098. https://doi.org/10.1038/bjc.2017.281
Catapano MC, Tvrdý V, Karlíčková J, Mercolini L, Mladěnka P (2018) A simple, cheap but reliable method for evaluation of zinc chelating properties. Bioorg Chem 77:287–292. https://doi.org/10.1016/j.bioorg.2018.01.015
Doerflinger M, Glab JA, Puthalakath H (2015) BH3-only proteins: a 20-year stock-take. FEBS J 282:1006–1016. https://doi.org/10.1111/febs.13190
Duarte D, Hawkins ED, Lo Celso C (2018) The interplay of leukemia cells and the bone marrow microenvironment. Blood 131:1507–1511. https://doi.org/10.1182/blood-2017-12-784132
Edlich F (2018) BCL-2 proteins and apoptosis: Recent insights and unknowns. Biochem Biophys Res Commun 500:26–34. https://doi.org/10.1016/j.bbrc.2017.06.190
Fatfat M et al (2014) Copper chelation selectively kills colon cancer cells through redox cycling and generation of reactive oxygen species. BMC Cancer 14:527. https://doi.org/10.1186/1471-2407-14-527
Galadari S, Rahman A, Pallichankandy S, Thayyullathil F (2017) Reactive oxygen species and cancer paradox: To promote or to suppress? Free Radic Biol Med 104:144–164. https://doi.org/10.1016/j.freeradbiomed.2017.01.004
Galluzzi L et al (2018) (2018) Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 25:486–541. https://doi.org/10.1038/s41418-017-0012-4
Hashemi M, Ghavami S, Eshraghi M, Booy EP, Los M (2007) Cytotoxic effects of intra and extracellular zinc chelation on human breast cancer cells. Eur J Pharmacol 557:9–19. https://doi.org/10.1016/j.ejphar.2006.11.010
Hunger SP, Mullighan CG (2015) Acute Lymphoblastic Leukemia in Children. N Engl J Med 373:1541–1552. https://doi.org/10.1056/NEJMra1400972
Kim SJ, Kim HS, Seo YR (2019) Understanding of ROS-Inducing Strategy in Anticancer Therapy. Oxid Med Cell Longev 2019:5381692. https://doi.org/10.1155/2019/5381692
Kinumi T, Kimata J, Taira T, Ariga H, Niki E (2004) Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. Biochem Biophys Res Commun 317:722–728. https://doi.org/10.1016/j.bbrc.2004.03.110
Li B et al (2014) Zinc is essential for the transcription function of Nrf2 in human renal tubule cells in vitro and mouse kidney in vivo under the diabetic condition. J Cell Mol Med 18:895–906. https://doi.org/10.1111/jcmm.12239
Liu J, Wang Z (2015) Increased oxidative stress as a selective anticancer therapy. Oxid Med Cell Longev 2015:294303. https://doi.org/10.1155/2015/294303
Marini M, Frabetti F, Canaider S, Dini L, Falcieri E, Poirier GG (2001) Modulation of caspase-3 activity by zinc ions and by the cell redox state. Exp Cell Res 266:323–332. https://doi.org/10.1006/excr.2001.5222
Mendivil-Perez M, Velez-Pardo C, Jimenez-Del-Rio M (2012) TPEN induces apoptosis independently of zinc chelator activity in a model of acute lymphoblastic leukemia and ex vivo acute leukemia cells through oxidative stress and mitochondria caspase-3- and AIF-dependent pathways. Oxid Med Cell Longev 2012:313275. https://doi.org/10.1155/2012/313275
Mendivil-Perez M, Velez-Pardo C, David-Yepes GE, Fox JE, Jimenez-Del-Rio M (2021) TPEN exerts selective anti-leukemic efficacy in ex vivo drug-resistant childhood acute leukemia. Biometals 34:49–66. https://doi.org/10.1007/s10534-020-00262-0
Nagata S (2000) Apoptotic DNA Fragmentation. Exp Cell Res 256:12–18. https://doi.org/10.1006/excr.2000.4834
Nakano K, Vousden KH (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7:683–694. https://doi.org/10.1016/s1097-2765(01)00214-3
Neuzil J, Dong LF, Rohlena J, Truksa J, Ralph SJ (2013) Classification of mitocans, anti-cancer drugs acting on mitochondria. Mitochondrion 13:199–208. https://doi.org/10.1016/j.mito.2012.07.112
O’Dwyer KM, Liesveld JL (2017) Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in older adults: Current treatment and novel therapies. Best Pract Res Clin Haematol 30:184–192. https://doi.org/10.1016/j.beha.2017.08.001
Oskarsson T et al (2016) Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: prognostic factors, treatment and outcome. Haematologica 101:68–76. https://doi.org/10.3324/haematol.2015.131680
Perillo B et al (2020) ROS in cancer therapy: the bright side of the moon. Exp Mol Med 52:192–203. https://doi.org/10.1038/s12276-020-0384-2
Prieto-Bermejo R, Romo-Gonzalez M, Perez-Fernandez A, Ijurko C, Hernandez-Hernandez A (2018) Reactive oxygen species in haematopoiesis: leukaemic cells take a walk on the wild side. J Exp Clin Cancer Res 37:125. https://doi.org/10.1186/s13046-018-0797-0
Rafei H, Kantarjian HM, Jabbour EJ (2019) Recent advances in the treatment of acute lymphoblastic leukemia. Leuk Lymphoma 60:2606–2621. https://doi.org/10.1080/10428194.2019.1605071
Rahal ON, Fatfat M, Hankache C, Osman B, Khalife H, Machaca K, Muhtasib HG (2016) Chk1 and DNA-PK mediate TPEN-induced DNA damage in a ROS dependent manner in human colon cancer cells. Cancer Biol Ther 17:1139–1148. https://doi.org/10.1080/15384047.2016.1235658
Ramyar A et al (2009) Cytologic phenotypes of B-cell acute lymphoblastic leukemia-a single center study. Iran J Allergy Asthma Immunol 8:99–106
Rojas-Valencia L, Velez-Pardo C, Jimenez-Del-Rio M (2017) Metal chelator TPEN selectively induces apoptosis in K562 cells through reactive oxygen species signaling mechanism: implications for chronic myeloid leukemia. Biometals 30:405–421. https://doi.org/10.1007/s10534-017-0015-0
Samudio I, Konopleva M, Carter B, Andreeff M (2010) Apoptosis in leukemias: regulation and therapeutic targeting. Cancer Treat Res 145:197–217. https://doi.org/10.1007/978-0-387-69259-3_12
Sillar JR, Enjeti AK (2019) Targeting Apoptotic Pathways in Acute Myeloid Leukaemia. Cancers (basel). https://doi.org/10.3390/cancers11111660
Soto-Mercado V, Mendivil-Perez M, Uruena-Pinzon C, Fiorentino S, Velez-Pardo C, Jimenez-Del-Rio M (2018) TPEN exerts antitumor efficacy in murine mammary adenocarcinoma through an H2O2 signaling mechanism dependent on caspase-3 Anticancer Agents. Med Chem 18:1617–1628. https://doi.org/10.2174/1871520618666180426111520
Stramucci L, Pranteda A, Bossi G (2018) Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in Cancer. Cancers (basel). https://doi.org/10.3390/cancers10050131
Stuart CH, Singh R, Smith TL, D’Agostino R Jr, Caudell D, Balaji KC, Gmeiner WH (2016) Prostate-specific membrane antigen-targeted liposomes specifically deliver the Zn(2+) chelator TPEN inducing oxidative stress in prostate cancer cells. Nanomedicine (lond) 11:1207–1222. https://doi.org/10.2217/nnm-2015-0017
Tang ZM et al (2020) Biodegradable nanoprodrugs: “delivering” ros to cancer cells for molecular dynamic therapy. Adv Mater 32:e1904011. https://doi.org/10.1002/adma.201904011
Wang L et al (2018) Small-Molecule Inhibitors Disrupt let-7 Oligouridylation and Release the Selective Blockade of let-7 Processing by LIN28. Cell Rep 23:3091–3101. https://doi.org/10.1016/j.celrep.2018.04.116
Woo JS, Alberti MO, Tirado CA (2014) Childhood B-acute lymphoblastic leukemia: a genetic update Exp. Hematol Oncol 3:16. https://doi.org/10.1186/2162-3619-3-16
Xiao Z, Ehrlich E, Luo K, Xiong Y, Yu XF (2007) Zinc chelation inhibits HIV Vif activity and liberates antiviral function of the cytidine deaminase APOBEC3G. FASEB J 21:217–222. https://doi.org/10.1096/fj.06-6773com
Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B (2001) PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 7:673–682. https://doi.org/10.1016/s1097-2765(01)00213-1
Yu Z et al (2019) Zinc chelator TPEN induces pancreatic cancer cell death through causing oxidative stress and inhibiting cell autophagy. J Cell Physiol 234:20648–20661. https://doi.org/10.1002/jcp.28670
Zhu B et al (2017) Zinc Depletion by TPEN induces apoptosis in human acute promyelocytic NB4 Cells Cell. Physiol Biochem 42:1822–1836. https://doi.org/10.1159/000479539
Zou Z, Chang H, Li H, Wang S (2017) Induction of reactive oxygen species: an emerging approach for cancer therapy. Apoptosis 22:1321–1335. https://doi.org/10.1007/s10495-017-1424-9